CommercialCoverageMedium impact
Augmentative and Alternative Communication Systems (e.g., Speech-generating Devices) 1.01.03
Excellus BlueCross BlueShield·NY · Neurology, Pediatrics, PM&R (Physical Medicine & Rehab) +2 more·Durable Medical Equipment & Supplies
Effective date
Aug 21, 2025
We identified it
Jun 20, 2026
Summary
Excellus BlueCross BlueShield has implemented a comprehensive new policy for coverage of Augmentative and Alternative Communication Systems (AACs) and Speech Generating Devices (SGDs), effective August 21, 2025. The policy establishes strict requirements including formal speech-language pathologist evaluations, mandatory one-month trials, and specific documentation for coverage approval.
Action Required
By August 21, 2025: Providers treating patients needing AACs/SGDs must ensure formal written evaluations by qualified speech-language pathologists include all 6 required elements (communication impairment description, technological assessment, functional goals, treatment plan, one-month trial request, and usage history). Update documentation templates to capture cognitive/physical ability assessments and ensure SLPs have no financial relationship with device suppliers. For pediatric patients, complete IEP assessment through school district before submitting coverage requests.